5 AI Companies Using Epidemiology to Fight Coronavirus

Apr 1, 2020 | Blog | 0 comments

Daniel Gigante

In the AI vs COVID-19 battle there are three major areas where breakthroughs are needed, coming and have arrived: diagnosis, treatment and epidemiology. In this post, we focus on five companies who are using epidemiology to aid researchers and the general public in the fight against COVID-19.

1. Qventus – Qventus is an AI-based software platform that optimizes patient flow across the hospital including emergency departments and inpatient units. With respect to COVID-19, Qventus helps in two ways (1) with a free epidemiological model that predicts COVID cases and capacity of key resources at a local (metropolitan) level on a daily basis; and (2) with AI-based interventions for COVID command centers, which provide leaders with situational awareness across the health system and allow them to optimize usage of critical resources such as Med-Surg beds, ICU beds, negative airflow isolation rooms, and ventilators.

2. AgileMD – AgileMD offers a mobile-optimized platform that delivers clinical manuals, protocols, and policies for point-of-care use. With respect to COVID-19, they’ve successfully deployed clinical pathways for inpatient, ambulatory, and the emergency room workflows within the electronic health record. They’re currently offering their software and services free to any compatible hospitals facing COVID-19.

3. Akido Labs – Akido Labs partners with large healthcare organizations to help them harness and leverage the power of their data. They’re providing emergency services coordination, disease surveillance, stress monitoring, and testing coordination as part of their COVID-19 response program.

4. Traces – Traces utilizes artificial intelligence to analyze video using 2000 different attributes of a person, except their face. The team feels their software can be used to trace who came into close proximity with those diagnosed. They’re currently offering their product free of charge, to existing customers.

5. Biobot – Biobot develops technology to transform sewers into public health observatories. Their plan is to analyze sewage samples from more than 100 cities across the country with the goal of figuring out how many people have contracted the coronavirus and how quickly it’s spreading.

This list is far from exhaustive, but we hope it provides some insight into the amazing work some companies are doing in the fight against coronavirus.


Submit a Comment

Your email address will not be published. Required fields are marked *

Large Pharma’s Embrace of Artificial Intelligence

The benefits of computational drug development are well known and accepted by many in the pharmaceutical space. However, since the onset of the global pandemic, consensus went from it being an interesting concept that was almost certainly the future, to something we need implemented as soon as possible. This is one of the few silver linings of the coronavirus outbreak.

The depth, vision and progress of EVQLV

Our CEO, Andrew Satz, recently spoke at Columbia University School of General Studies’ “Alumni in Action.” The subject of his talk was artificial intelligence. One of the questions posed to Andrew was what we were doing outside of coronavirus, along with the long term plans of our company

EVQLV Applies Proprietary AI Technology in Collaboration with Twist Bioscience to Discover and Validate Novel Antibody Therapies

EVQLV, Inc., an artificial intelligence-enabled technology company accelerating biologics discovery, announced today a collaboration with Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, to discover novel antibody-based therapies.

EVQLV’s Evolutionary Algorithm Explained

Brett Averso (CTO, EVQLV) and Bhoomika Kumar (SciTech intern, EVQLV) teamed up to provide a high-level overview of how EVQLV’s evolutionary algorithm works.

Andrew Satz on the Talent Finders Podcast

EVQLV’s CEO, Andrew Satz, joined Kerrin Black of the Talent Finders Podcast to discuss his entrepreneurial journey, some of the challenges facing AI for drug discovery, his legacy and much more.

Pin It on Pinterest